Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Today, a crushing Phase 3 failure for Ultragenyx in Angelman syndrome, a new accelerator from Nobel laureate David Baker to use AI to map nature’s design rules, and more.
The sniffly 5-year-old in my bed is coloring a remarkable green-blue rainbow at present. Visionary, truly.
This article is exclusive to STAT+ subscribers #
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? [Log in](/login/)
[View All Plans](https://www.statnews.com/stat-plus/)
source & further reading
statnews.com — original article
STAT+: OpenEvidence launches new family of AI models
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
STAT+: How a former ARPA-H director’s startup is tackling AI’s ‘dumb problems’